Regulatory Intelligence Management

The Regulatory Intelligence (RI) Management system leverages artificial intelligence to streamline the management of regulatory intelligence for pharmaceutical and biotech companies. It facilitates the continuous process of gathering, analyzing, and applying regulatory data and trends, which is crucial for strategic decision-making throughout the product lifecycle. This system supports organizations from early development stages to post-market surveillance, ensuring compliance and efficiency in a complex global regulatory landscape.

Why Regulatory Intelligence Matters

Regulatory guidelines are constantly evolving, and failing to keep track can lead to approval delays or costly non-compliance issues. Pharma and biotech companies face the challenge of navigating diverse standards across global markets. Regulatory intelligence provides visibility into emerging trends, competitor strategies, and agency expectations, enabling faster and more informed decision-making across research and development, clinical, and regulatory affairs teams.

Qualcy Core Services

• AI Global Regulatory Monitoring: This service tracks evolving requirements from agencies such as the FDA, EMA, MHRA, PMDA, and NMPA, providing real-time updates tailored to specific therapeutic areas and geographies.
• AI Competitive Intelligence: Analyze regulatory filings, approval timelines, and strategies to better position your product pipeline and optimize submission processes.
• Strategic Planning Support: Align regulatory strategies with development milestones to reduce the risk of rework and accelerate time-to-market.
• Knowledge Sharing: Receive intelligent, actionable alerts based on market changes, guidance updates, advisory committee recommendations, and more, through dashboards and newsletters.

For those interested in exploring the capabilities of this system, a demo and a 30-day free trial are available. The company is committed to ensuring 100% customer satisfaction.